Clinician Challenge

Participate in polls and see how your answers relate to your colleagues'.

Jul 18, 2024According to Dr Forlenza's presentation, while most people using Control I-Q technology bolus every day, nearly 1 in 10 have gone 7+ days without bolusing with no increased hypoglycemia.
May 31, 2024Which is true about the t:slim X2 insulin pump?
Apr 4, 2024What have been some specific changes for Corine (PwD) while using a smart insulin pen?
Mar 28, 2024As discussed by Dr Ahn and Melissa (PwD), what is her issue of most concern?
Mar 15, 2024Which of the below conditions have specifically improved for PwD Jasmin, using the Smart Insulin Pen in partnership with Dr Jones?
Dec 1, 2023Some of the benefits of smart insulin pens (SIPs) for people on MDI are that they can:
Nov 3, 2023Some of the benefits smart insulin pens (SIPs) provide to people on MDI are:
Sep 1, 2023Which below medication is currently in Phase 3 clinical development for the treatment of NASH?
Aug 24, 2023According to DiabetesWise Pro (pro.diabeteswise.org), one/some of the best ways to introduce a diabetes technology device to a patient is/are:
Jan 12, 2023A/some of the unique thing(s) about Omnipod 5 insulin pump is/are:
Dec 7, 2022Per Dr Isaacs' presentation, statistics show that most people with type 2 diabetes have hepatic steatosis.
Aug 16, 2022A study to evaluate the safety and effectiveness of the Omnipod 5 System over 12 months of use in children with T1D aged 2 to <6 demonstrated 49% achieved HbA1c of <7.0% compared with 31% at baseline.
May 25, 2022The implantable sensor of the newly FDA approved 180-days CGM system measures in length as the diameter of which of the following US coins?
Mar 25, 2022The PROMISE study, published in Diabetes Technology & Therapeutics in February 2022, was completed in order to evaluate:
Jan 6, 2022AID systems provide benefit and may reduce patient's self care burden
Dec 22, 2021As discussed by Dr Forlenza in his presentation, "Novel AID Systems on the Horizon," some forthcoming innovative features are:
Nov 19, 2021As presented by Dr Buckingham, recent clinical trials of a novel automated insulin delivery (AID) system vs. standard therapy (ST) in both adults and children show:
Oct 22, 2021Recent studies of a novel AID system for pediatric and young adults population demonstrated:
Sep 17, 2021From AACE Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus, published 2021
Aug 25, 2021A recent pivotal study of a novel AID system, revealed:
Aug 20, 2021What are device factors to consider when helping your patient select an AID system?
Aug 19, 2021Per Dr Hirsch, core components of Smart Insulin Pens include:
Aug 5, 2021Per Dr Hirsch, smart insulin pens allow patients and providers to see granularity of insulin dosing such as "missed/late doses and calculated dosing to avoid stacking":
Jul 30, 2021Which is correct?
Jul 22, 2021Time-in-range outcomes from a recent clinical study of a novel tubeless AID system revealed:
Jul 15, 2021The use of a bolus calculator feature in novel smart insulin pens benefits people with diabetes by:
Jun 18, 2021Cutting-edge features of a novel Smart Insulin Pen with Advanced Decision support could include which of the following innovations:
Jun 17, 2021Clinical trial of the Omnipod 5 system confirms:
Jun 10, 2021What clinical improvements should be expected from novel AID systems?
Jun 3, 2021Smart Insulin Pen users benefit from individualized digital tools similar to those found in insulin pumps, but with lower cost and the freedom of not being continuously tethered to a pump.
May 25, 2021Cohort studies and managed care data analysis of insulin pen usage compared with vial and syringe users, confirm which of the following:
May 20, 2021As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated:
Apr 22, 2021Clinical trials data and case studies to be presented by Distinguished Faculty on May 6th at the www.cgmEDUCATION.net Diabetes Technology Roundtable V, report which, regarding novel Insulin Pumps and AID systems?
Apr 1, 2021As presented during the DTR IV, Novel AID systems scheduled to be introduced in the near future will have which of the following innovative features?
Dec 18, 2020A June 2020 published article by Dr Hirsch et al on real-world insulin delivery, reports:
Nov 19, 2020As presented during the DTR III, can pump/CGM combinations attain consistent TIR for adults and children?
Oct 29, 2020As presented during the DTR III, 'Pod pumps' are a good fit for older T2s since Medicare will often not approve tubed pumps for this population.
Oct 9, 2020As presented by Dr Diana Isaacs during the DTR II, Glooko Data Uploads show which of the following statistics with respect to Omnipod and CGM users maintaining time in range (TIR 70-180 m/dl) in the US and Canada?
Oct 2, 2020According to Diana Isaacs, PharmD in the Diabetes Technology Roundtable II, and the ADA Standards of Care in Diabetes 2020 guidelines, who can benefit from insulin pump therapy?
Sep 25, 2020According to Dr Gregory Forlenza in the Diabetes Technology Roundtable II, some advantages of using an insulin pump are:
Aug 6, 2020Per a recently published article, onboarding and in-the-moment management via telehealth of a new-onset type 1 diabetes pediatric patient at Barbara Davis Center in Colorado, successfully used which combination of diabetes devices?
Jul 29, 2020A recent article on telemedicine by Drs Garg, Rodbard, Hirsch and Forlenza, concludes which of the following?
Jun 23, 2020While insulin pumps have been used in the United States for more than 30 years, recent statistics estimated which of the following regarding the percentage of patients with Type 2 diabetes utilizing pumps?
Jun 17, 2020Findings from a 3-month, multicenter, retrospective study on Type 2 Diabetes treatment with a tubeless insulin pump, showed:
Jun 12, 2020Which of the following is true regarding Type 2 Diabetes (T2D) treatment with insulin pumps?
Jun 3, 2020Which of the following is true according to the article, Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes?
Apr 24, 2020Smart insulin pens may have which of the following features:
Apr 10, 2020Which of the following is/are correct as discussed in the article by TS Bailey et al, A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice:
Mar 11, 2020Which of the following feature(s) is/are part of integrated smart insulin pen systems?
Feb 27, 2020According to an article in Medical News Today an observational study from 2015 showed that diabetes patients using insulin pens are:
Feb 21, 2020In 2019, the FDA approved the first Bluetooth enabled insulin pen:
Feb 14, 2020The first insulin pen was introduced in...
Feb 7, 2020The first known mention of diabetes symptoms, frequent urination as a symptom of a mysterious disease that also caused emaciation, was documented in...
Jan 31, 2020What causes insulin resistance and prediabetes, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)?
Jan 24, 2020The HypoDE randomized control trial demonstrated that:
Jan 17, 2020According to the American Diabetes Association, 84 million American adults have prediabetes; how many of them don't know they have it?
Dec 30, 2019The Center for Disease Control (CDC)* released a report on 12.30.19 stating which of the following:
Dec 19, 2019According to a 2005-2016 study of 5,786 US adolescents (aged 12 to 18) and young adults (aged 19 to 34), recently published in JAMA Pediatrics1, which of the following is the emerging health threat that can lead to type 2 diabetes:
Nov 21, 2019In 1916, Boston scientist Elliott Joslin established himself as one of the world's leading diabetes experts by creating the textbook The Treatment of Diabetes Mellitus, which reported which of the following:
Oct 25, 2019Please select the correct statement below.
Mar 15, 2019The I HART CGM study concluded that:
Feb 14, 2019Who can bill for current procedural terminology (CPT) CGM code 95251?
Jan 31, 2019Which one of the following statement(s) is(are) correct of CGM use according to findings from the DIaMonD and GOLD studies:
Nov 16, 2018What are some requirements for CGM as durable medical equipment (DME) to be eligible for Medicare coverage?
Nov 9, 2018With the use of CGM, clinicians are now able to treat their patients differently by:
Oct 11, 2018Which of the following is an important consideration when giving a post-meal insulin bolus with the aid of CGM based trend arrows dosing in order to avoid hypoglycemia in persons using multiple daily insulin therapy?
Sep 13, 2018What are ideal criteria to use continuous glucose monitoring (CGM)?
Aug 15, 2018Real-time continuous glucose monitoring (rtCGM) facilitates our understanding of the relationship between:
Jul 19, 2018Which of the following is true regarding the clinical evidence supporting real-time continuous glucose monitoring (rtCGM) as a standard of care?
May 24, 2018The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:
May 3, 2018The GOLD trial was notable for providing evidence that:
Mar 20, 2018While wearing CGM, patients should consider:
Jan 19, 2018The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Oct 26, 2017The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Sep 21, 2017The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...
Mar 14, 2017The best candidates for CGM may include...
Jan 9, 2017Previous studies involving patients with T1D have shown that...
Jan 5, 2017With CGM, what is the role of the pharmacist?
Dec 6, 2016What is most important when evaluating CGM?
Nov 18, 2016In your experience, what have most studies about CGM demonstrated?
Jun 12, 2014What percentage of your patients would benefit from Real-Time CGM?
cgmEDUCATION.net is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, and Tandem Diabetes Care, Inc.
©2024 CogniMed Inc. All rights reserved.